info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cell Tissue Preservation Market Research Report By Method (Cryopreservation, Vitrification, Controlled Cooling), By Application (Cell Preservation, Tissue Preservation, Organ Preservation), By Product Type (Cryoprotectants, Preservation Solutions, Storage Containers), By End User (Research Laboratories, Biotechnology Companies, Hospitals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032


ID: MRFR/HC/35535-HCR | 100 Pages | Author: Rahul Gotadki| November 2024

Global Cell Tissue Preservation Market Overview:


As per MRFR analysis, the Cell Tissue Preservation Market Size was estimated at 8.06 (USD Billion) in 2022. The Cell Tissue Preservation Market Industry is expected to grow from 8.41 (USD Billion) in 2023 to 12.3 (USD Billion) by 2032. The Cell Tissue Preservation Market CAGR (growth rate) is expected to be around 4.32% during the forecast period (2024 - 2032).


Key Cell Tissue Preservation Market Trends Highlighted


The Cell Tissue Preservation Market is witnessing significant growth driven by an increasing demand for organ transplantation, advancements in preservation techniques, and a rise in research activities in cellular therapies. The need for effective tissue preservation techniques to prolong the viability of cells and organs during storage and transportation is becoming more critical. Key market drivers also include the rising aging population and the growing prevalence of chronic diseases, which collectively propel the demand for more sophisticated preservation solutions. There are ample opportunities to be explored, particularly in developing regions where healthcare infrastructure is evolving.


As more countries enhance their medical facilities, the need for effective preservation solutions is expected to rise. Innovations in preservation methods, such as the development of cryoprotectants and improved freezing techniques, also provide avenues for growth. Moreover, partnerships between academic institutions and biotechnology companies can lead to breakthroughs in preservation technologies, further expanding the market landscape. Recent trends highlight the increasing focus on regenerative medicine and personalized therapies. 


This shift towards customized treatments has intensified the need for reliable preservation solutions, as the quality and viability of tissues are paramount to successful patient outcomes.The trend towards automation in preservation processes is also evident, leading to improved efficiency and lower risk of human error. Additionally, the growing awareness about the importance of tissue preservation in various medical processes supports market expansion. As the landscape evolves, stakeholders in the market are likely to benefit from these trends, enhancing both research capabilities and therapeutic applications.


Global Cell Tissue Preservation Market Overview


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Cell Tissue Preservation Market Drivers


Increasing Demand for Transplants and Regenerative Medicine


The Cell Tissue Preservation Market Industry is being driven by the escalating demand for organ transplants and advancements in regenerative medicine. With an aging population and increasing prevalence of chronic diseases, there is a growing need for cell and tissue preservation to ensure the viability of organs and cells for transplantation. This demand is further amplified by the advancements in biotechnology and regenerative medicine, which necessitate the need for high-quality preserved cells and tissues to develop effective therapies.The efficiency and outcomes of transplantation procedures are highly dependent on the quality of preserved tissues, thereby boosting the demand in the Cell Tissue Preservation Market Industry. The continuous research and development efforts in the field of cell and tissue engineering also contribute to the growing requirements for efficient preservation techniques. There is also a shift towards personalized medicine; hence, reliable preservation methods are essential for the development of patient-specific therapies.This increasing focus on improving transplant success rates highlights the critical role that cell tissue preservation plays in the healthcare sector, strengthening market growth and innovation pathways in the Cell Tissue Preservation Market Industry.


Technological Advancements in Preservation Techniques


Technological advancements are significantly impacting the Cell Tissue Preservation Market Industry. Innovative preservation technologies such as cryopreservation, biobanking, and advanced storage systems are enhancing the quality and longevity of preserved tissues and cells. These advancements not only improve the efficiency of preservation processes but also ensure better recovery rates and functionality post-thaw. The incorporation of automated systems in the preservation processes minimizes human error and enhances reproducibility, leading to increased confidence in the outcomes of tissue and cell therapies.Such innovations are attracting significant investments and are expected to result in enhanced market growth opportunities. As technology continues to evolve, the market is likely to witness the development of more sophisticated preservation methodologies, further driving expansion within the Cell Tissue Preservation Market Industry.


Rising Investments in Healthcare and Biotech Research


Rising investments in healthcare and biotechnology research are becoming a crucial driver for the Cell Tissue Preservation Market Industry. There is an increasing recognition of the importance of preserving biological materials for research, clinical, and therapeutic purposes. Government initiatives and funding programs aimed at enhancing research capabilities are contributing to advancements in preservation techniques and technologies. This surge in financial resources dedicated to the life sciences sector is resulting in increased awareness about the applications of preserved cells and tissues in drug development, disease modeling, and personalized medicine.The collaboration between public and private entities fosters innovation, boosting the overall growth prospects for the industry while encouraging the development of novel preservation solutions within the Cell Tissue Preservation Market Industry.


Cell Tissue Preservation Market Segment Insights:


Cell Tissue Preservation Market Method Insights


The Cell Tissue Preservation Market, with a notable revenue of 8.41 USD Billion in 2023, comprises diverse methods crucial for preserving cells and tissues for research and therapeutic applications. Among these, Cryopreservation stands out as the leading method, showing a valuation of 3.36 USD Billion in 2023, which is expected to increase to 4.93 USD Billion by 2032. Its significant majority holding in the market stems from its extensive usage in biobanking, reproductive medicine, and stem cell preservation. Cryopreservation's ability to maintain cell viability during freezing processes makes it a vital technique in the life sciences.


Following Cryopreservation, Vitrification holds a substantial position with a market valuation of 2.63 USD Billion in 2023, projected to reach 3.8 USD Billion by 2032. This method's rising popularity is driven by its efficiency in preserving oocytes and embryos, ensuring higher survival rates compared to traditional cooling methods. Its application in assisted reproductive technologies has led to increased demand, making Vitrification a significant player in the market landscape.Controlled Cooling, with a valuation of 2.42 USD Billion in 2023 and a projected rise to 3.57 USD Billion in 2032, is another essential method in the Cell Tissue Preservation Market. Though it represents the least dominance among the three methods, its relevance cannot be underestimated. Controlled Cooling offers benefits like reducing cellular stress during the preservation process and is predominantly applied in specific laboratory settings. The diverse applications of these methodologies emphasize the market's dynamic nature as it adapts to advancements in cell and tissue preservation technologies.


Overall, the Cell Tissue Preservation Market segmentation by method reveals critical insights into market trends and growth drivers. An increase in research activities, rising investments in biotechnology, and a growing focus on personalized medicine substantially fuel the market’s growth, while challenges such as regulatory hurdles and high costs of preservation techniques present certain setbacks. However, the ongoing evolution and development of these methods continue to yield opportunities for enhancing preservation efficiencies and expanding applications across various industries, thereby affirming the importance of each method in the broader market context.


Cell Tissue Preservation Market Method Insights


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Cell Tissue Preservation Market Application Insights


The Cell Tissue Preservation Market is projected to be valued at 8.41 billion USD in 2023 and focuses on crucial applications within the field, specifically Cell Preservation, Tissue Preservation, and Organ Preservation. Each application plays a vital role in enhancing medical procedures, such as transplantation, by ensuring the viability of cells and tissues for longer durations. Among these, cell preservation is essential for research and therapeutic purposes, as it maintains cell functionality over time. Tissue preservation is also significant as it supports regenerative medicine, enabling the development of treatments from preserved tissues.Organ preservation is particularly critical, as it is fundamental in the field of organ transplantation, affecting patient outcomes. The Cell Tissue Preservation Market segmentation illustrates the growing need for advanced preservation technologies, driven by increasing healthcare demand, advancements in preservation methods, and a rising number of transplant procedures. Moreover, improved healthcare infrastructure and growing awareness regarding organ donation further bolster this market. However, challenges such as regulatory hurdles and stringent storage requirements persist.Overall, the Cell Tissue Preservation Market data reflects sustained growth potential, presenting opportunities for innovation and development within its various applications.


Cell Tissue Preservation Market Product Type Insights


The Cell Tissue Preservation Market is projected to reach a valuation of 8.41 billion USD in 2023, reflecting a growing demand driven by advancements in biobanking and regenerative medicine. Within the Product Type segment, major categories include Cryoprotectants, Preservation Solutions, and Storage Containers, each playing a crucial role in the preservation process. Cryoprotectants hold a significant share as they prevent ice crystal formation during freezing, ensuring cellular integrity, which is vital for successful transplantation. Preservation Solutions are essential for maintaining cell viability during storage, highlighting their importance in research and therapeutic applications.Storage Containers dominate this segment due to their critical role in safeguarding biological samples under controlled conditions, influencing the overall efficiency of preservation practices. As the market evolves, trends towards personalized medicine and the increasing focus on stem cell research are expected to drive demand across these categories, contributing to the overall Cell Tissue Preservation Market growth. Furthermore, ongoing advancements in preservation technologies offer opportunities to enhance product effectiveness and broaden their applications in healthcare.


Cell Tissue Preservation Market End User Insights


The Cell Tissue Preservation Market is a growing field characterized by diverse end users, primarily comprising research laboratories, biotechnology companies, and hospitals. In 2023, the market value reached approximately 8.41 USD Billion, reflecting the rising demand for effective preservation techniques in various sectors. Research laboratories play a crucial role by requiring preservation solutions for cellular specimens, which is vital for advancing scientific exploration and medical research. Biotechnology companies significantly impact this market, focusing on innovative solutions that enhance the viability of cell and tissue products for therapeutic applications.Hospitals also hold a pivotal position as they utilize preservation methods for transplantable organs and tissues, thereby addressing critical healthcare needs. The strategic importance of these end users in driving adoption and innovation in the Cell Tissue Preservation Market underscores their influence in determining market growth and shaping future trends. Overall, the focus on improving storage solutions indicates a progressive trajectory for the industry, reflecting an increasing awareness of the critical role preservation plays across these sectors.


Cell Tissue Preservation Market Regional Insights


The Cell Tissue Preservation Market is experiencing notable growth across various regions, with a total market valuation expected to reach 8.41 billion USD in 2023. North America leads the regional segmentation, holding a significant market value of 3.5 billion USD, projected to rise to 5.2 billion USD by 2032, making it the dominant player due to advanced healthcare infrastructure and high investment in biotechnological research. Europe follows, with a market valuation of 2.5 billion USD in 2023 that is anticipated to grow to 3.8 billion USD, driven by robust regulatory frameworks and increasing demand for organ transplants and regenerative medicine.The APAC region, valued at 1.8 billion USD in 2023, shows significant potential for growth to 2.4 billion USD, fueled by rising healthcare expenditure and a growing population needing preservation solutions. South America and MEA are on the lower end of the spectrum, registering market values of 0.3 billion USD and 0.31 billion USD in 2023, respectively, yet these regions present emerging opportunities as healthcare systems advance and awareness of cell and tissue preservation techniques is enhanced. Overall, the Cell Tissue Preservation Market is characterized by its diversified regional dynamics, each contributing uniquely to the overall market growth.


Cell Tissue Preservation Market Regional Insights


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Cell Tissue Preservation Market Key Players and Competitive Insights:


The Cell Tissue Preservation Market has become an integral component of biobanking and regenerative medicine, highlighting the importance of maintaining cellular integrity during storage and transportation. As the demand for biological samples grows in research and clinical applications, competition within the market intensifies. Key players in this industry strategically position themselves to leverage advancements in preservation technologies, emphasizing quality and efficiency to meet evolving customer needs. The competitive landscape is shaped by innovative solutions, strategic partnerships, and a focus on regulatory compliance, enabling companies to differentiate their offerings in a rapidly changing environment.BioLife Sciences has established a formidable presence in the Cell Tissue Preservation Market through its commitment to developing innovative preservation solutions. The company prides itself on offering cutting-edge products that ensure the viability and functionality of cellular materials during storage. BioLife Sciences maintains a strong reputation for quality, which has enabled it to build trust with a diverse range of clients, including academic and pharmaceutical research institutions. Its key strengths lie in its robust research and development capabilities, allowing the company to continuously enhance its product offerings. This focus on innovation, coupled with a keen understanding of market demands, positions BioLife Sciences favorably against competitors, ensuring that it plays a vital role in advancing the landscape of cell and tissue preservation.StemExpress operates within the Cell Tissue Preservation Market with a focus on providing high-quality biospecimens and related services. The company's position is bolstered by its rigorous quality control measures and its extensive network for sourcing and processing biological materials. StemExpress is recognized for its ability to offer specialized and customized solutions that meet the diverse needs of its clients in the research and clinical sectors. The strengths of StemExpress lie in its operational efficiency and its commitment to ethical practices, which resonate well with a market increasingly concerned about the integrity and transparency of sourcing biological samples. By delivering excellence in service and maintaining a client-centric approach, StemExpress effectively navigates the competitive dynamics of the market, ensuring its offerings remain relevant and highly sought after.


Key Companies in the Cell Tissue Preservation Market Include:



  • BioLife Sciences

  • StemExpress

  • Lonza Group

  • Viagen Biotech

  • Thermo Fisher Scientific

  • Reviva Pharmaceuticals

  • Corning Incorporated

  • Aastrom Biosciences

  • CryoCell International

  • Merck KGaA

  • CellPreservation

  • Span Medical

  • Xvivo Perfusion

  • Cell Preservation

  • BD


Cell Tissue Preservation Market Industry Developments


Recent developments in the Cell Tissue Preservation Market have highlighted significant advancements and collaborations among key players. Companies such as BioLife Sciences, StemExpress, and Lonza Group continue to innovate their preservation technologies to enhance cell viability and integrity during storage, catering to the growing demand in regenerative medicine and biobanking. Thermo Fisher Scientific has recently expanded its product portfolio, introducing new preservation solutions that boost storage capabilities for sensitive biospecimens. Additionally, the landscape has seen increased merger and acquisition activities, particularly among prominent entities, reflecting a trend toward consolidation to leverage complementary technologies and market share. Notable acquisitions include the strategic partnership between Merck KGaA and Reviva Pharmaceuticals aimed at advancing cell preservation methodologies. Market valuation is also on the rise, driven by the increasing need for biopreservation in therapeutic applications, which is positively impacting the overall growth trajectory. Companies like CryoCell International and Xvivo Perfusion are especially benefiting from this momentum as they enhance their services and products to meet regulatory and market demands in cell tissue preservation. The market is rapidly evolving, showcasing innovation and strategic alignment among major stakeholders in the industry.


Cell Tissue Preservation Market Segmentation Insights



  • Cell Tissue Preservation Market Method Outlook

    • Cryopreservation

    • Vitrification

    • Controlled Cooling





  • Cell Tissue Preservation Market Application Outlook

    • Cell Preservation

    • Tissue Preservation

    • Organ Preservation





  • Cell Tissue Preservation Market Product Type Outlook

    • Cryoprotectants

    • Preservation Solutions

    • Storage Containers





  • Cell Tissue Preservation Market End User Outlook

    • Research Laboratories

    • Biotechnology Companies

    • Hospitals





  • Cell Tissue Preservation Market Regional Outlook

    • North America

    • Europe

    • South America

    • Asia Pacific

    • Middle East and Africa



Report Attribute/Metric Details
Market Size 2022 8.06 (USD Billion)
Market Size 2023 8.41 (USD Billion)
Market Size 2032 12.3 (USD Billion)
Compound Annual Growth Rate (CAGR) 4.32% (2024 - 2032)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year 2023
Market Forecast Period 2024 - 2032
Historical Data 2019 - 2023
Market Forecast Units USD Billion
Key Companies Profiled BioLife Sciences, StemExpress, Lonza Group, Viagen Biotech, Thermo Fisher Scientific, Reviva Pharmaceuticals, Corning Incorporated, Aastrom Biosciences, CryoCell International, Merck KGaA, CellPreservation, Span Medical, Xvivo Perfusion, Cell Preservation, BD
Segments Covered Method, Application, Product Type, End User, Regional
Key Market Opportunities Biobanking expansion needs, Technological advancements in preservation, Rising demand for organ transplants, Increasing research funding, Regulatory support for tissue preservation
Key Market Dynamics Increasing demand for organ transplants, Advancements in preservation technologies, Rise in biobanking initiatives, Growing focus on regenerative medicine, Stringent regulatory frameworks
Countries Covered North America, Europe, APAC, South America, MEA


Frequently Asked Questions (FAQ) :

The Cell Tissue Preservation Market is projected to reach a value of 12.3 billion USD by 2032.

The market is expected to grow at a CAGR of 4.32% from 2024 to 2032.

North America is expected to hold the largest market share, valued at 5.2 billion USD in 2032.

The Cryopreservation method is estimated to have a market value of 4.93 billion USD in 2032.

The Vitrification market is expected to be worth 3.8 billion USD by 2032.

Controlled Cooling is projected to reach a market value of 3.57 billion USD in 2032.

Major players include BioLife Sciences, StemExpress, and Thermo Fisher Scientific, among others.

The market size for the Cell Tissue Preservation Market in Europe is expected to reach 3.8 billion USD by 2032.

The Asia-Pacific region is estimated to have a market size of 2.4 billion USD by 2032.

Challenges in the market include regulatory hurdles and the need for standardization in preservation methods.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.